Interpace Diagnostics Shows Pancreatic Cyst Test Improves Patient Management

Feb 03, 2016

|

Premium

NEW YORK (GenomeWeb) – Molecular diagnostics developer Interpace Diagnostics has announced the publication of a multicenter study demonstrating that its PancraGen molecular test for pancreatic cysts improved outcomes for patients and helped doctors monitor patients with benign disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Whirlwind Genetic Genealogy Year

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Getting Through the Backlog

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

Settlement After DNA Testing Questions

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

This Week in Nature

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

Featured White Papers

Epigenomic Analysis of Sorted Retinal Ganglion Cells using ATAC-seq

Cloning Bovine Immunoglobulin VH and VL Genes from Single B Cells

Automated RT qPCR Utilizing the Access Workstation, the Echo Liquid Handler, and RealTime Ready Reagents from Roche Applied Science

High-throughput Miniaturized Quantitative PCR with the Echo 525 Liquid Handler

May

08

Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May

22

Featured Webinar

A Digital PCR Liquid Biopsy Workflow for Mutation Detection and Therapeutic Monitoring

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.

Menu